Is regulation in a healthy place? A conversation with Ed Smith and Peter Wyman3rd April 2017
How can regulation support providers to deliver care and health services in a rapidly evolving environment where technology, an ageing population and limited budgets create opportunities and challenges? This informal, in-conversation-styled event will be an opportunity to hear first-hand, frank insights from Peter Wyman, Chair of CQC and Ed Smith, Chair of NHS Improvement on the future of regulation.
This event has kindly been hosted by Odgers Berndston
What impact will Brexit have on the life sciences?26th April 2017
The UK has long been a world-leader for innovation in life sciences. Which is why, according to the Office for Life Sciences, many of the most talented scientists from other countries come here to research and develop innovative drugs and technologies. However the affects of the UK leaving the EU is a grey area.
The UK Prime Minister has said she intends to trigger Article 50 by the end of March 2017, meaning the UK will be expected to have left the EU by the summer of 2019.
We have brought together leaders from across the healthcare landscape to discuss the opportunities, challenges and predictions of the impact of Brexit on the life sciences.
Confirmed speakers are Liz Mear, CEO, The Innovation Agency and Dr Nicole Mather, Director, Office for Life Sciences.
This event is kindly being hosted by EY.